Runtime: 33:47
We’d love to hear from you so that we can create the best possible podcast for primary care providers. Once you’ve finished listening, please take our short (5-minute) evaluation here.
SHOW NOTES
Summary
In this episode, host David P. Ball dives into the topic of managing benzodiazepine use in primary care. He’s joined by Bill Nelles, a former AIDS nurse and counsellor with lived experience of benzodiazepine use, and Dr. Megan Hill, a family doctor who has worked in addiction medicine for over 10 years. Together, they offer practical insights for care providers supporting patients to manage or reduce benzodiazepine use. Through real-world examples and grounded clinical advice, the episode highlights how structured, compassionate care can make a meaningful difference.
Learning Objectives
- Identify how to approach meeting a new client in primary care who has been on benzodiazepines long-term for insomnia, anxiety, or other conditions.
- Examine and optimize underlying conditions and age-related factors.
- Employ best practices for a benzodiazepine taper, transitioning to alternative therapies, and supporting clients through dependency.
Lineup
In this episode, you’ll hear:
- [2:00] – Bill Nelles, Guest – Former nurse and counsellor
- [15:13] – Dr. Megan Hill, Guest – Primary care family physician, sub-specializing in addiction medicine, Interior Health
Clinical Pearls
Here’s what listeners can take away from this episode:
- Utilize brief intervention each appointment to understand and collaborate on goals with the patient, allowing incremental progress with each interaction.
- A slow and steady taper is better than cutting the patient off abruptly. Any momentum is good, and a slow taper also allows relationship and trust to build over time.
- When preparing for a taper, optimize any concurrent conditions (such as anxiety, seizure or sleep disorders, etc.) first by referring to specialist care to help assure them that their underlying conditions will be addressed and that the taper is safe. Educate the patient that withdrawal from benzodiazepines can sometimes mimic the underlying condition.
- Differentiating between physiological dependence and a use disorder will help determine the course of treatment. There are some medications available to treat withdrawal while adjusting to lower dose and other remedies like CBT, mindfulness, meditation, etc.
- Prepare for appointments by having tools and resources that you can pull up quickly to share with the patient, such as referral sources for counsellors. This can help make a shorter appointment be more efficient.
Resources
Supports for care providers
- Choosing Wisely Canada. Drowsy without Feeling Lousy: A toolkit for reducing inappropriate use of benzodiazepines and sedative-hypnotics among older adults in primary care. Published April 2023. https://choosingwiselycanada.org/wp-content/uploads/2017/12/CWC-Toolkit-BenzoPrimaryCare-V3.pdf Accessed April 2, 2026.
- Choosing Wisely Canada. Less Sedatives for your Relatives: A toolkit for reducing inappropriate use of benzodiazepines and sedative-hypnotics among adults in hospitals. Updated May 2024. https://choosingwiselycanada.org/toolkit/less-sedatives-for-your-relatives/ Accessed April 2, 2026.
Resources for patients, families, friends and loved ones
- Deprescribing.Org. Infographic: Benzodiazepines and Z-Drugs. Published August 2018. https://deprescribing.org/wp-content/uploads/2018/08/Deprescribing-focus-on-BZRAs-FINAL-August2018_CC.pdf Accessed April 2, 2026.
- Pathways: Community Service Directory. https://pathwaysbc.ca/community
- Pathways: Medical Service Directory. https://pathwaysmedicalcare.ca/
- Sleepwell. Patient-facing resources for getting a good night’s sleep using cognitive behavioural therapy for insomnia and other non-pharmacological approaches. https://mysleepwell.ca/
Reports, statistics, and guidance
- BC Centre on Substance Use. Benzodiazepines: Best Practices in Primary Care. Published May 2025. https://www.bccsu.ca/wp-content/uploads/2025/05/benzodiazepine-bulletin.pdf Accessed April 2, 2026.
- BC Centre on Substance Use. Clinical Bulletin: Benzodiazepine-adulterated Opioids. Published February 2026. https://www.bccsu.ca/wp-content/uploads/2026/02/benzodiazepine-adulterated-opioids-clinical-bulletin.pdf Accessed April 2, 2026.
- Canadian Centre on Substance Use and Addiction. Canadian Drug Summary: Sedatives. Updated May 2022. https://www.ccsa.ca/sites/default/files/2019-06/CCSA-Canadian-Drug-Summary-Sedatives-2019-en.pdf Accessed April 2, 2026.
- Canadian Centre on Substance Use and Addiction. CCENDU Bulletin: Risks and Harms Associated with the Nonmedical Use of Benzodiazepines in the Unregulated Drug Supply in Canada. Published December 2021. https://www.ccsa.ca/sites/default/files/2021-12/CCSA-CCENDU-Nonmedical-Use-Benzodiazepines-Unregulated-Drug-Supply-Bulletin-2021-en.pdf Accessed April 2, 2026.
- Deprescribing.Org. Deprescribing Guidelines and Algorithms: Benzodiazepine Receptor Agonists. https://deprescribing.org/resources/deprescribing-guidelines-algorithms/ Accessed April 2, 2026.
Articles
- Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial. JAMA Intern Med. 2014;174(6):890–898. doi:10.1001/jamainternmed.2014.949